ROIV
Roivant Sciences Ltd.
Stock
$35.72+0.22 (+0.62%)Close Oct 2, 2026
- EBITDA, FY2025
- −$512M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| FY2025 | −$512M | — |
| FY2024 | −$989M | — |
| FY2023 | $4.5B | — |
| FY2022 | −$888M | — |
| FY2021 | −$1.3B | — |
Roivant Sciences Ltd.
$35.72+0.22 (+0.62%)Close Oct 2, 2026
| Period | EBITDA | YoY |
|---|---|---|
| FY2025 | −$512M | — |
| FY2024 | −$989M | — |
| FY2023 | $4.5B | — |
| FY2022 | −$888M | — |
| FY2021 | −$1.3B | — |